Division Director
US Food and Drug Administration
Dr. Liang Zhao has been serving as the Director of Division of Quantitative Methods and Modeling (DQMM), Office of Research and Standards, Office of Generic Drugs, CDER/FDA since 2015. He has demonstrated excellence and leadership in drug development and regulatory science in regulatory and industrial settings for new and generic drugs during his 18+ professional tenue including in Pharsight as an associate consultant, BMS as a research investigator, MedImmune as an Associate Director, FDA as Clinical Pharmacology reviewer and Pharmacometrics team leader. He has started several regulatory initiatives including concepting model master files for model sharing and implemented model integrated evidence for generic product development and approval. Dr. Zhao has introduced a broad array of innovative tools in the realm of drug deliveries and bioequivalence assessment, as well as big data tools including machine learning to pharmacometrics. He so far has published 100+ articles and book chapters including a broad array of prestigious journals.
Opening Session brought to you by Genentech
Wednesday, March 22, 2023
3:00 PM – 4:00 PM EDT